Uncategorized

FY27 Medicare reimbursement proposals for inpatient hospitals [HCA, THC, CYH, ARDT, UHS, MPT, muni-backed systems] largely met expectations for a smaller increase, versus FY26, with most changes appearing formulaic and math-based rather than policy-led. Despite…

In the past week, the House and Senate have introduced bipartisan legislation known as the MATCH Act, or the Multilateral Alignment of Technology Controls on Hardware Act, which poses headline risk for ASML (ASML) and Tokyo Electron (TOELY). The legislative measure is designed to tighten U.S. export controls on semiconductor manufacturing equipment…

The recent social media verdicts in New Mexico and California raise the valuation question for investors about how far P/Es might fall for META (META) and (Alphabet) GOOGL assuming litigation risks continue and potentially intensifies. History’s answer is that the path isn’t linear. In different cases, it took the market time…

While we view today’s update of Medicare Administrative Contractor (MAC) WPS’s billing and coding article for hypoglossal nerve stimulation (HGNS) – omitting requirements that physicians bill using a -52 (reduced work) modifier – as directionally…

We estimate that iRhythm (IRTC) faces a 1%-2% growth headwind from a finalized local coverage determination (LCD) on ambulatory cardiac monitoring (ACM), likely to be released in the coming weeks. While we expect the company’s…

With government policy in flux and CY/FY27 payment updates coming into focus, we outline key 2Q potential policy catalysts and debates for health insurers and providers. While CMS’s improved CY27 Medicare Advantage rates offer a…

We had the following takeaways from last week’s conference call we hosted on the recent verdicts in the META and GOOGL trials in New Mexico and California with two lawyers who are very familiar with similar Internet cases. A transcript or audio recording of the call is available…

The final CY27 Medicare Advantage (MA) rate announcement, reflecting a net 2.48% YoY benchmark increase, landed within our expectations and alleviates some of the near term-pressure on MA insurers [HUM, ALHC, UNH, CVS, ELV, CNC]…

The White House’s biopharma tariffs announced last week [Fact Sheet] strike us as an aggressive effort to secure additional onshoring and most favored nation (MFN) pricing agreements with manufacturers, but the clock is likely ticking…

FY27 Medicare reimbursement proposals for skilled nursing facilities [ENSG, PACS] and related REITs [SBRA, OHI, LTC, CTRE], inpatient rehab facilities (IRFs) [EHC, SEM, Kindred]and inpatient psych facilities (IPFs) [UHS, ACHC] were broadly in-line with our…